HIV prevalence in KwaZulu-Natal: a call for increased circumcision awareness
Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...
pharmaphorum13h
Gilead's HIV success and controversy: Expanding access amid criticism
The company recently released phase 3 data showing that a twice-yearly treatment with lenacapavir was 100% effective in HIV ...
Success of long-lasting HIV drug hinges on pricing
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Radio Free Europe/Radio Liberty2d
HIV-Infected Patient Refused Care In Armenia
Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...
News Medical2d
Affordability and supply remain critical to the success of long-lasting HIV drug
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Metro Weekly2d
Multiple Paths to HIV Prevention: The Power of Choice
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Fred Hutch2d
Infectious disease experts propose trials network dedicated to immunocompromised patients
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
devdiscourse2d
UNAIDS Head Calls for Global Solidarity to Tackle Rising HIV Infections in Madagascar
"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...
HIV cases rising in Alberta, sparking need for broad outreach, experts say
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Business Wire4d
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Fighting the stigma: A Detroit HIV survivor shares his story to help others with virus
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
Science Daily4d
HIV and AIDS News
Improving HIV Treatment in Children and Adolescents -- The Right Way July 18, 2024 — Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in ...